Abstract
TA01 (molecular weight 35.0 kDa, isoelectric point 5.45) and TA02 (molecular weight 35.0 kDa, isoelectric point 5.29) polypeptides were detected using two-dimensional polyacrylamide gel electrophoresis (2-DE). A previous study has shown that these polypeptides are distributed in primary adenocarcinomas and some large-cell carcinomas of the lung. However, various expression levels of TA01 and TA02 polypeptides were demonstrated in adenocarcinoma, while large-cell carcinoma expressed low levels. To evaluate the relationship between the expression of TA01 and TA02 polypeptides and the histocytological features of primary adenocarcinoma of the lung, these two polypeptides were analysed by 2-DE combined with a non-enzymatic sample preparation technique, and their expression levels were compared with the histocytological features of primary lung adenocarcinoma. Out of 57 primary lung adenocarcinoma cases, 46 cases (80.7%) and 52 cases (91.2%) expressed TA01 and TA02 polypeptides respectively. Furthermore, the expression levels of TA01 and TA02 polypeptides correlated with the degree of cellular atypia, structural atypia and histocytological differentiation of primary lung adenocarcinoma. On the other hand, these two polypeptides were not detected in adenocarcinoma of the lung, metastatic from the colon and mammary glands. High expression of TA01 and TA02 polypeptides reflected the differentiation of primary adenocarcinoma in the lung. These two polypeptides are valuable in determining the histocytological differentiation of primary lung adenocarcinoma as well as in distinguishing between primary and metastatic adenocarcinoma of the lung.
Full text
PDF







Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Auten R. L., Watkins R. H., Shapiro D. L., Horowitz S. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am J Respir Cell Mol Biol. 1990 Nov;3(5):491–496. doi: 10.1165/ajrcmb/3.5.491. [DOI] [PubMed] [Google Scholar]
- Bernard A., Roels H., Lauwerys R., Witters R., Gielens C., Soumillion A., Van Damme J., De Ley M. Protein 1 is a secretory protein of the respiratory and urogenital tracts identical to the Clara cell protein. Clin Chem. 1992 Mar;38(3):434–435. [PubMed] [Google Scholar]
- Bhattacharya B., Prasad G. L., Valverius E. M., Salomon D. S., Cooper H. L. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res. 1990 Apr 1;50(7):2105–2112. [PubMed] [Google Scholar]
- Bjellqvist B., Basse B., Olsen E., Celis J. E. Reference points for comparisons of two-dimensional maps of proteins from different human cell types defined in a pH scale where isoelectric points correlate with polypeptide compositions. Electrophoresis. 1994 Mar-Apr;15(3-4):529–539. doi: 10.1002/elps.1150150171. [DOI] [PubMed] [Google Scholar]
- Buccheri G., Ferrigno D. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer. Chest. 1988 Mar;93(3):565–570. doi: 10.1378/chest.93.3.565. [DOI] [PubMed] [Google Scholar]
- Carney D. N., Marangos P. J., Ihde D. C., Bunn P. A., Jr, Cohen M. H., Minna J. D., Gazdar A. F. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet. 1982 Mar 13;1(8272):583–585. doi: 10.1016/s0140-6736(82)91748-2. [DOI] [PubMed] [Google Scholar]
- Celis J. E., Rasmussen H. H., Madsen P., Leffers H., Honoré B., Dejgaard K., Gesser B., Olsen E., Gromov P., Hoffmann H. J. The human keratinocyte two-dimensional gel protein database (update 1992): towards an integrated approach to the study of cell proliferation, differentiation and skin diseases. Electrophoresis. 1992 Dec;13(12):893–959. doi: 10.1002/elps.11501301198. [DOI] [PubMed] [Google Scholar]
- Costa A., Silvestrini R., Mochen C., Lequaglie C., Boracchi P., Faranda A., Vessecchia G., Ravasi G. P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer. Br J Cancer. 1996 Apr;73(7):914–919. doi: 10.1038/bjc.1996.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebina M., Steinberg S. M., Mulshine J. L., Linnoila R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res. 1994 May 1;54(9):2496–2503. [PubMed] [Google Scholar]
- Franzén B., Linder S., Okuzawa K., Kato H., Auer G. Nonenzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1993 Oct;14(10):1045–1053. doi: 10.1002/elps.11501401167. [DOI] [PubMed] [Google Scholar]
- Garrels J. I., Franza B. R., Jr Transformation-sensitive and growth-related changes of protein synthesis in REF52 cells. A two-dimensional gel analysis of SV40-, adenovirus-, and Kirsten murine sarcoma virus-transformed rat cells using the REF52 protein database. J Biol Chem. 1989 Mar 25;264(9):5299–5312. [PubMed] [Google Scholar]
- Gazdar A. F., Linnoila R. I. The pathology of lung cancer--changing concepts and newer diagnostic techniques. Semin Oncol. 1988 Jun;15(3):215–225. [PubMed] [Google Scholar]
- Gazdar A. F., Zweig M. H., Carney D. N., Van Steirteghen A. C., Baylin S. B., Minna J. D. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res. 1981 Jul;41(7):2773–2777. [PubMed] [Google Scholar]
- Hirano T., Franzén B., Uryu K., Okuzawa K., Alaiya A. A., Vanky F., Rodrigues L., Ebihara Y., Kato H., Auer G. Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma. Br J Cancer. 1995 Oct;72(4):840–848. doi: 10.1038/bjc.1995.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirsch F. R., Matthews M. J., Aisner S., Campobasso O., Elema J. D., Gazdar A. F., Mackay B., Nasiell M., Shimosato Y., Steele R. H. Histopathologic classification of small cell lung cancer. Changing concepts and terminology. Cancer. 1988 Sep 1;62(5):973–977. doi: 10.1002/1097-0142(19880901)62:5<973::aid-cncr2820620521>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- Kibbelaar R. E., Moolenaar K. E., Michalides R. J., Van Bodegom P. C., Vanderschueren R. G., Wagenaar S. S., Dingemans K. P., Bitter-Suermann D., Dalesio O., Van Zandwijk N. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer. 1991;27(4):431–435. doi: 10.1016/0277-5379(91)90379-r. [DOI] [PubMed] [Google Scholar]
- Letanche G., Ogier I., Weynants P., Hartmann D. J., Ville G., Cordier J. F., Brune J. Valeur diagnostique du dosage de l'antigène carbohydrate 19-9 (CA 19-9) chez les patients porteurs de cancer bronchique primitif. Rev Pneumol Clin. 1985;41(5):314–316. [PubMed] [Google Scholar]
- Linnoila R. I., Jensen S. M., Steinberg S. M., Mulshine J. L., Eggleston J. C., Gazdar A. F. Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am J Clin Pathol. 1992 Feb;97(2):233–243. doi: 10.1093/ajcp/97.2.233. [DOI] [PubMed] [Google Scholar]
- Maruno K., Yamaguchi K., Abe K., Suzuki M., Saijo N., Mishima Y., Yanaihara N., Shimosato Y. Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma. Cancer Res. 1989 Feb 1;49(3):629–632. [PubMed] [Google Scholar]
- Morrissey J. H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem. 1981 Nov 1;117(2):307–310. doi: 10.1016/0003-2697(81)90783-1. [DOI] [PubMed] [Google Scholar]
- Mørkve O., Halvorsen O. J., Stangeland L., Gulsvik A., Laerum O. D. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer. 1992 Dec 2;52(6):851–855. doi: 10.1002/ijc.2910520603. [DOI] [PubMed] [Google Scholar]
- Niklinski J., Furman M. Clinical tumour markers in lung cancer. Eur J Cancer Prev. 1995 Apr;4(2):129–138. doi: 10.1097/00008469-199504000-00002. [DOI] [PubMed] [Google Scholar]
- Nomori H., Shimosato Y., Kodama T., Morinaga S., Nakajima T., Watanabe S. Subtypes of small cell carcinoma of the lung: morphometric, ultrastructural, and immunohistochemical analyses. Hum Pathol. 1986 Jun;17(6):604–613. doi: 10.1016/s0046-8177(86)80133-2. [DOI] [PubMed] [Google Scholar]
- O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
- Ochs D. C., McConkey E. H., Guard N. L. Vimentin-derived proteins: differences between normal human fibroblasts and transformed human cells. Exp Cell Res. 1981 Oct;135(2):355–362. doi: 10.1016/0014-4827(81)90171-3. [DOI] [PubMed] [Google Scholar]
- Okuzawa K., Franzén B., Lindholm J., Linder S., Hirano T., Bergman T., Ebihara Y., Kato H., Auer G. Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1994 Mar-Apr;15(3-4):382–390. doi: 10.1002/elps.1150150157. [DOI] [PubMed] [Google Scholar]
- Rachwal W. J., Bongiorno P. F., Orringer M. B., Whyte R. I., Ethier S. P., Beer D. G. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas. Br J Cancer. 1995 Jul;72(1):56–64. doi: 10.1038/bjc.1995.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radice P. A., Matthews M. J., Ihde D. C., Gazdar A. F., Carney D. N., Bunn P. A., Cohen M. H., Fossieck B. E., Makuch R. W., Minna J. D. The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer. 1982 Dec 15;50(12):2894–2902. doi: 10.1002/1097-0142(19821215)50:12<2894::aid-cncr2820501232>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- Scagliotti G. V., Micela M., Gubetta L., Leonardo E., Cappia S., Borasio P., Pozzi E. Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer. 1993;29A(3):363–365. doi: 10.1016/0959-8049(93)90387-u. [DOI] [PubMed] [Google Scholar]
- Singh G., Singh J., Katyal S. L., Brown W. E., Kramps J. A., Paradis I. L., Dauber J. H., Macpherson T. A., Squeglia N. Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem. 1988 Jan;36(1):73–80. doi: 10.1177/36.1.3275712. [DOI] [PubMed] [Google Scholar]
- Vincent R. G., Chu T. M., Lane W. W. The value of carcinoembryonic antigen in patients with carcinoma of the lung. Cancer. 1979 Aug;44(2):685–691. doi: 10.1002/1097-0142(197908)44:2<685::aid-cncr2820440241>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]